To investigate circulating tumour DNA as a biomarker of resistance in metastatic uveal melanoma treated with PKC inhibitor (LXS196)

Project: Other

Project Details

AcronymMISC_Sydney Vital
StatusFinished
Effective start/end date1/07/1830/06/19